Journal of Thyroid Disorders & Therapy
Open Access

Department of Endocrinology and Metabolism, Institute for Integrative and Conscious Health (ISIC), París, 3r 1a Barcelona, Spain

Biography

Dr. Isabel García is a dedicated endocrinologist at the Institute for Integrative and Conscious Health (ISIC) in Barcelona, Spain. She earned her medical degree from the Universitat Autònoma de Barcelona in 2006, training at Hospital del Mar. Driven by a passion for hormonal health, she completed her residency in Endocrinology and Nutrition at Hospital Universitari de Bellvitge. During her residency, Dr. García recognized the profound impact of psychological factors on physical health, prompting her to pursue training in Gestalt Therapy at Institut Integratiu from 2010 to 2013. She further expanded her expertise with a Master's in Naturopathy from ISMET and a postgraduate degree in Psychoneuroimmunoendocrinology from a center affiliated with the University of Barcelona. At ISIC, Dr. García integrates conventional endocrinology with complementary therapies, emphasizing a holistic approach to patient care. She advocates for active patient participation in health management, focusing on natural and sustainable treatment methods. In 2021, she co-authored the "Consensus Document on the Diagnosis and Treatment of Hashimoto's Autoimmune Thyroiditis," published in the Journal of Thyroid Disorders & Therapy. This work examines the etiopathogenic factors of Hashimoto's disease, aiming to enhance therapeutic and preventive strategies.

Publications

• Research Article   
  Etiopathogenetic Mechanisms in Hashimoto?s Autoimmune Thyroid Disease
  Author(s): Isabel García* and Sergio Abanades
  
  Hashimoto’s disease (HD) is an autoimmune thyroid disease often leading to hypothyroidism. The current therapy for these patients consists in traditional Hormone Replacement Therapy (HRT) to compensate inadequate thyroid function. However, clinical management of this and other autoimmune disorders usually dismisses the etiologic component, even when the gold-standard pharmacological treatment is not effective and/or the patient remains asymptomatic. Here, we propose to dig into the etiopathogenic factors as an attempt to unravel patient’s negative response to therapy and to improve therapeutic and preventive approaches as standard medical practice as well as to complement HRT. These factors may include genetic susceptibility, intestinal permeability defects, other pathologies like celiac disease, gluten intolerance and biopsychosocialstress, gender, se.. View More»
  

  Abstract HTML PDF

Other relevant publications from this author

• https://isic-bcn.com/professional/isabel-garcia/?utm_source=chatgpt.com

  Etiopathogenetic Mechanisms in Hashimoto?s Autoimmune Thyroid Disease